{"nct_id":"NCT02392611","title":"Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer","status":"COMPLETED","status_verified_date":"2020-12","start_date":"2015-03-16","start_date_type":"ACTUAL","primary_completion_date":"2017-10-11","primary_completion_date_type":"ACTUAL","completion_date":"2017-10-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}